2024 Hot Topic in Basic & Translational Science: Tolerance & Resistance (HTTR ) to Targeted Therapy in Non-Small Cell Lung Cancer (NSCLC)

2024 Hot Topic in Basic & Translational Science: Tolerance & Resistance (HTTR ) to Targeted Therapy in Non-Small Cell Lung Cancer (NSCLC) is organized by International Association for the Study of Lung Cancer (IASLC) and will be held from Dec 13 - 15, 2024 at Hilton Washington DC National Mall The Wharf, Washington, Dist of Col, United States of America.

Description:
IASLC’s Hot Topic Meetings in Basic and Translational Science serve as a platform to share cutting-edge research, discuss challenges in the field, and explore collaborative opportunities among academic and with industrial researchers to advance the understanding and treatment of non-small cell lung cancer. The expected audience includes basic scientists, translational researchers, oncologists, pathologists, molecular biologists, radiologists, pharmaceutical and biotech professionals, academic researchers, students, and more. The multidisciplinary nature of the audience reflects the comprehensive approach required to address the complexities of tolerance and resistance to targeted therapy in non-small cell lung cancer. The meeting aims to foster collaboration and knowledge exchange among professionals with complementary expertise to advance the understanding and treatment of NSCLC.

Why Attend HTTR 2024?
This conference is a premier gathering of leading minds in lung and thoracic cancer research. It offers a unique platform to discuss the latest advancements, share groundbreaking research, and collaborate with experts from around the world. Attendees will gain insights into the molecular and cellular processes behind treatment tolerance and resistance, as well as explore new therapeutic strategies and translational insights that bridge the gap between basic research and clinical application. The meeting will feature a diverse audience, including scientists, clinicians, pathologists, radiologists, and industry professionals, reflecting the multidisciplinary approach necessary to tackle the complexities of NSCLC. Through engaging presentations, networking opportunities, and collaborative discussions, we aim to inspire innovative solutions and chart the future direction of lung cancer research and treatment.

Note: Access to the HTTR 2024 Online Platform will be provided to all registered delegates in early December 2024.